RE: Positive17 Jan 2021 08:31
Correct the Times article refers to SP. Short snippet:
The share price of Novacyt, an Anglo-French specialist in diagnostic testing, rose 6,147 per cent in 12 months, while Synairgen, a drug discovery firm, is up 2,306 per cent after trials of a treatment for Covid-19.
Not the article we wanted but exposure none the less.